SEOM clinical guidelines for the management of metastatic breast cancer 2013

Llombart Cussac, A; Haba Rodríguez, J de la; Ruiz Simón, A; Álvarez López, I; Cortés Castán, J.
Clin. transl. oncol. (Print) ; 15(12): 1004-1010, dic. 2013. tab
Artículo en Inglés | IBECS (España) | ID: ibc-127707

Documentos relacionados

  1. Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.
  2. Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
  3. Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome.
  4. Systemic Therapy of Central Nervous System Metastases of Breast Cancer.
  5. Economic burden of central nervous system metastases in human epidermal growth factor receptor 2-positive breast cancer.
  6. Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.
  7. Prognostic factors and outcome of HER2+ breast cancer with CNS metastases.
  8. A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?
  9. Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.
  10. Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.